REFERENCES
- Wagner LK. Diagnosis and management of preeclampsia. Am Fam Physician 2004; 70:2317–2324.
- Witlin AG, Sibai BM. Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol 1998; 92:883–889.
- Chappell S, Morgan L. Searching for genetic clues to the causes of pre-eclampsia. Clin Sci (Lond) 2006; 110:443–458.
- Cheng MH, Wang PH. Placentation abnormalities in the pathophysiology of preeclampsia. Expert Rev Mol Diagn 2009; 9:37–49.
- Ward K. Searching for genetic factors underlying pre-eclampsia: recent progress and persistent challenges. Minerva Ginecol 2008; 60:399–419.
- Nejatizadeh A, Stobdan T, Malhotra N, Pasha MA. The genetic aspects of pre-eclampsia: achievements and limitations. Biochem Genet 2008; 46:451–479.
- Symonds EM, Broughton Pipkin F, Craven DJ. Changes in the renin-angiotensin system in primigravidae with hypertensive disease of pregnancy. Br J Obstet Gynaecol 1975; 82:643–650.
- Lie RT, Rasmussen S, Brunborg H, Gjessing HK, Lie-Nielsen E, Irgens LM. Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ 1998; 316:1343–1347.
- Chesley LC, Annitto JE, Cosgrove RA. The familial factor in toxemia of pregnancy. Obstet Gynecol 1968; 32:303–311.
- Cincotta RB, Brennecke SP. Family history of pre-eclampsia as a predictor for pre-eclampsia in primigravidas. Int J Gynaecol Obstet 1998; 60:23–27.
- Arngrimsson R, Björnsson S, Geirsson RT, Björnsson H, Walker JJ, Snaedal G. Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. Br J Obstet Gynaecol 1990; 97:762–769.
- Dawson LM, Parfrey PS, Hefferton D, Dicks EL, Cooper MJ, Young D, Marsden PA. Familial risk of preeclampsia in Newfoundland: a population-based study. J Am Soc Nephrol 2002; 13:1901–1906.
- Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001; 357:53–56.
- Wilton AN, Cooper DW, Brennecke SP, Bishop S, Marshall P. Absence of close linkage between maternal genes for susceptibility to pre-eclampsia/eclampsia and the HLA DRB. Lancet 1990; 2:653–657.
- Humphrey KE, Harrison GA, Cooper DW, Wilton AN, Brennecke SP. HLA-G deletion polymorphism and preeclamptic/eclampsia. Br J Obstet Gynaecol 1995; 102:707–710.
- Hubel CA, Roberts JM, Ferrell RE. Association of pre-eclampsia with common coding sequence variations in the lipoprotein lipase gene. Clin Genet 1999; 56:289–296.
- Chikosi AB, Moodley J, Pegoraro RJ, Lanning PA, Rom L. 5,10-Methylenetetrahydrofolate reductase polymorphism in black South African women with pre-eclampsia. Br J Obstet Gynaecol 1999; 106:1219–1220.
- Kahn SR. Severe preeclampsia associated with coinheritance of factor V Leiden mutation and protein S deficiency. Obstet Gynecol 1998; 91:812–814.
- Chikosi AB, Moodley J, Pegoraro RJ. Apolipoprotein E polymorphism in pre-eclampsia. S Afr Med J 2000; 90:128–129.
- López-Jaramillo P, Herrera JA, Arenas-Mantilla M, Jáuregui IE, Mendoza MA. Subclinical infection as a cause of inflammation in preeclampsia. Am J Ther 2008; 15:373–376.
- Lachmeijer AM, Dekker GA, Pals G, Aarnoudse JG, ten Kate LP, Arngrímsson R. Searching for preeclampsia genes: the current position. Eur J Obstet Gynecol Reprod Biol 2002; 105:94–113.
- Wilson ML, Goodwin TM, Pan VL, Ingles SA. Molecular epidemiology of preeclampsia. Obstet Gynecol Surv 2003; 58:39–66.